No Data
No Data
Oragenics | 10-K: Annual report
Express News | Oragenics Submits Investigator's Brochure Application For Phase II Clinical Trial Of ONP-002 In Australia
Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (MTBI)
Oragenics, Inc. to Present Concussion Treatment Advancements at Emergencies in Medicine Conference
Press Release: Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
Oragenics, Inc. Partners With BRAINBox Solutions to Develop Innovative Intranasal Therapy for Concussion Management